BBY vs NEO · P/E 14, rev $18.71B vs rev $388.3M
Best Buy Co. Inc (BBY) versus NeoGenomics Inc (NEO) — a side-by-side from cached financials, not a winner call.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
NeoGenomics Inc (NEO) is a diagnostics & research company listed on US.
Latest reported BBY revenue for 2026-08-01 was $18.71B. Net income was $591.0M. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
Latest reported NEO revenue for 2026-06-30 was $388.3M. Net income was -$14.9M. NEO currently screens at market cap $924.0M.
BBY currently screens at market cap $15.41B and trailing P/E 13.5. NEO currently screens at market cap $924.0M.
Not investment advice. Open the BBY and NEO stock pages for the full models.
Not investment advice.